Celldex Therapeutics, Inc. (CLDX)
39.42
+0.18
(+0.46%)
USD |
NASDAQ |
Sep 02, 10:41
Celldex Therapeutics Market Cap : 3.094B for Sept. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 01, 2026 | 3.080B |
| August 31, 2026 | 3.111B |
| August 28, 2026 | 3.071B |
| August 27, 2026 | 3.176B |
| August 26, 2026 | 3.185B |
| August 25, 2026 | 3.236B |
| August 24, 2026 | 3.185B |
| August 21, 2026 | 3.170B |
| August 20, 2026 | 3.135B |
| August 19, 2026 | 3.273B |
| August 18, 2026 | 3.281B |
| August 17, 2026 | 3.291B |
| August 14, 2026 | 3.293B |
| August 13, 2026 | 3.345B |
| August 12, 2026 | 3.522B |
| August 11, 2026 | 3.480B |
| August 10, 2026 | 3.373B |
| August 07, 2026 | 3.274B |
| August 06, 2026 | 3.262B |
| August 05, 2026 | 3.223B |
| August 04, 2026 | 3.065B |
| August 03, 2026 | 2.509B |
| July 31, 2026 | 2.534B |
| July 30, 2026 | 2.562B |
| July 29, 2026 | 2.497B |
| Date | Value |
|---|---|
| July 28, 2026 | 2.369B |
| July 27, 2026 | 2.373B |
| July 24, 2026 | 2.349B |
| July 23, 2026 | 2.358B |
| July 22, 2026 | 2.315B |
| July 21, 2026 | 2.374B |
| July 20, 2026 | 2.358B |
| July 17, 2026 | 2.353B |
| July 16, 2026 | 2.357B |
| July 15, 2026 | 2.550B |
| July 14, 2026 | 2.541B |
| July 13, 2026 | 2.565B |
| July 10, 2026 | 2.604B |
| July 09, 2026 | 2.595B |
| July 08, 2026 | 2.594B |
| July 07, 2026 | 2.658B |
| July 06, 2026 | 2.526B |
| July 02, 2026 | 2.554B |
| July 01, 2026 | 2.448B |
| June 30, 2026 | 2.477B |
| June 29, 2026 | 2.492B |
| June 26, 2026 | 2.347B |
| June 25, 2026 | 2.269B |
| June 24, 2026 | 2.249B |
| June 23, 2026 | 2.195B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 186.10B |
| Ionis Pharmaceuticals, Inc. | 9.930B |
| ACADIA Pharmaceuticals, Inc. | 5.019B |
| Alnylam Pharmaceuticals, Inc. | 34.05B |
| Anika Therapeutics, Inc. | 285.19M |
Market Cap Related Metrics
| PS Ratio | 17297.08 |
| PEG Ratio | -0.2014 |
| Price to Book Value | 4.331 |
| Price | 39.42 |
| Earnings Yield | -11.06% |
| PEGY Ratio | -0.2014 |